lung cancer
Conditions
Interventions
1:Ultrasound-guided parathymic block 0.375% ropivacaine injection 10 ml
2:Ultrasound-guided proximal sub-parietal subpleural block 0.375% ropivacaine injection 10 ml
3:Subpleural block of the proximal parietal layer under ultrasound guidance of 1 cm from the transverse process 20 ml of ropivacaine injection
4:Subpleural block of the proximal parietal layer under ultrasound guidance of 1 cm transverse protrusion 30 ml of ropivacaine injection 30 ml
5:Subpleural block of the proximal parietal layer under ultrasound guidance of 1 cm from the transverse process 40 ml of ropivacaine injection
6:1 cm-2 cm from the transverse process ultrasound-guided proximal wall subpleural block 0.375% ropivacaine injection 10 ml
7:Subpleural block of the proximal parietal layer under ultrasound guidance of 1 cm-2 cm from the transverse process 20 ml of ropivacaine injection
8:Subpleural block of the proximal parietal layer under ultrasound guidance 1 cm-2 cm from the transverse process is 0 ml of ropivacaine injection
9:Subpleural block of the proximal parietal layer 40 ml from the transverse protrusion 1 cm-2 cm subpleural block under ultrasound guidance 40 ml
10:0.375% rosipercaine injection 10 ml from the proximal wall subpleural block under ultrasound guidance of 2 cm-3 cm transverse process
11:Subpleural block of the proximal wall layer 2 cm-3 cm from the transverse process 2 cm-3 cm subpleural block 20 ml
12:Subpleural block of the proximal parietal layer under ultrasound guidance of 2 cm-3 cm from the transverse process is 30 ml of ropivacaine injection
13:Subpleural block of the proximal parietal layer 40 ml from the transverse process 2 cm-3 cm ultrasound-guided 0.375% ropivacaine injection
14:Subpleural block of the proximal parietal layer under ultrasound guidance of 3 cm-4 cm from the transverse process is 0.375% of ropivacaine injection 10 ml
15:Subpleural block 0.375% ropivacaine injection 20 ml from the proximal parietal subpleural block under ultrasound guidance of 3 cm
Sponsors
The Second Affiliated Hospital of Soochow University
Eligibility
Sex/Gender
All
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: Patients with radiofrequency ablation of liver tumors or lung tumors under the guidance of CT; Age = 18 years; ASA ratingS I-III.
Exclusion criteria
Exclusion criteria: Hypersensitivity to narcotic drugs; Long-term use of opioids; Infection at the site of puncture; Difficulty communicating; Iodine contrast agent allergy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The number of segments in which the local anesthetic solution spreads to the epidural; | — |
Secondary
| Measure | Time frame |
|---|---|
| The number of segments in which the local anesthetic solution spreads to the tail side;The skin feels hypokritically flat;The number of segments in which the local anesthetic solution spreads to the tail side;Count the number of segments in which the solution covers the anterior root of the spinal nerve;Count the number of segments in which the solution covers the nerve roots;Count the number of segments of the sympathetic nerve that the solution covers;The number of segments in which the local anesthetic solution spreads to the side of the head; | — |
Countries
China
Contacts
Public ContactJiang Zhu, Yong NI
The Second Affiliated Hospital of Soochow University
Outcome results
None listed